Delivery Order SPE2DR25D3103-SPE2DR26F9X13
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $11,535.36 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of December 16, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal vendor specializing in medical procurement for military and veteran healthcare systems. The delivery...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract valued at $1,734.42 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Ondansetron ODT 8 mg tablets. The contract has a completion date of January 26, 2024 and was awarded on January 25, 2024. Amerisourcebergen Drug Corp is the prime contractor and does not have any major subcontractors listed. This delivery order is...
- The Defense Logistics Agency awarded a $6,515.94 delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30-count packaging) with an ultimate completion date of August 12, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and was issued as a delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $1,678.08 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units) with an ultimate completion date of January 13, 2026. This non-set-aside, firm fixed-price delivery order was competitively awarded and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $8,035.99 to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30 count) on January 8, 2026, with a completion date of January 9, 2026. This is a firm fixed-price, non-set-aside contract with performance taking place at AmerisourceBergen's Conshohocken, Pennsylvania location. The award represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999,999,999...
- The Defense Logistics Agency awarded a delivery order valued at $3,554.96 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units). This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of July 15, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $1,284.44 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count packages). The award, issued on January 6, 2026, with an ultimate completion date of January 7, 2026, represents a firm fixed-price delivery order with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,629.35 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units) with a firm fixed price structure. This is a non-set-aside, competitively awarded contract with performance to be completed by December 3, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order worth $4,123.00 to Amerisourcebergen Drug Corp, a for-profit organization and subsidiary of Amerisourcebergen Corporation. The order is for the delivery of 4,563,803,471 units of the drug Ondansetron ODT 4 MG Tablet 30s to a location in Conshohocken, Pennsylvania. The order has a completion date of February 29, 2024. Amerisourcebergen Drug Corp serves as a prime contractor providing pharmaceutical products and...
- The Defense Logistics Agency awarded a $29,071.24 delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30-count packages) on September 4, 2025, with completion due by September 5, 2025. This is a firm fixed price, non-set-aside contract performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. As a child contract under a larger vehicle, this delivery order leverages AmerisourceBergen's Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX),...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F9X13Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $7,413.29 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count packaging) on January 14, 2026. This non-set-aside, firm fixed-price contract will be performed in Conshohocken, Pennsylvania, with an ultimate completion date of January 15, 2026. The award represents a routine pharmaceutical procurement under AmerisourceBergen's existing contract vehicle with DLA Troop Support Medical. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving federal healthcare systems, particularly the military and veteran medical supply chains. The company holds a significant Indefinite Delivery Contract with DLA Troop Support Medical valued at $999,999,999.00 through December 2026, which serves as the underlying vehicle for this delivery order. The contract enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies globally to support military healthcare programs, veterans' healthcare systems, and other federal medical institutions across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.4k | 1/13/26 |